We are live on ! Find out more

61 hedge funds and large institutions have $30.4M invested in cbdMD in 2021 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 17 increasing their positions, 14 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 6

21% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 14

17% more funds holding

Funds holding: 5261 (+9)

0.01% less ownership

Funds ownership: 0.06%0.05% (-0.01%)

10% less call options, than puts

Call options by funds: $907K | Put options by funds: $1.01M

32% less capital invested

Capital invested by funds: $44.5M → $30.4M (-$14.1M)

Holders
61
Holders Change
+9
Holders Change %
+17.31%
% of All Funds
1.06%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
15
Increased
17
Reduced
14
Closed
6
Calls
$907K
Puts
$1.01M
Net Calls
-$100K
Net Calls Change
-$332K

YCBD Hedge Fund Activity: Q2 2021 in Review

61 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in cbdMD (YCBD) for Q2 2021, worth a combined $30.4M — down 32% from $44.5M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new YCBD positions and 6 closed out — a net gain of 9 holders — while 17 added to existing stakes and 14 trimmed.

The largest buyer was Vanguard Group, adding an estimated $629K. The largest seller was AdvisorShares Investments, cutting an estimated $945K.

  • 61 institutional investors held cbdMD (YCBD) as of Q2 2021, up from 52 in Q1 2021.
  • Funds reported $30.4M of cbdMD stock for Q2 2021, down 32% quarter-over-quarter.
  • 15 funds opened new cbdMD positions in Q2 2021 and 6 closed out, a net change of +9 holders.
  • The largest cbdMD buyer in Q2 2021 was Vanguard Group, an estimated $629K added.
  • The largest cbdMD seller in Q2 2021 was AdvisorShares Investments, an estimated $945K sold.

Based on aggregated 13F filings for Q2 2021.